Description:
MYOPATHY, CENTRONUCLEAR, 1; CNM1
DYNAMIN 2; DNM2
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Muscular Dystrophies
CMD Specific
PIGI Consented Sample |
| Class |
Congenital Muscle Diseases |
| Quantity |
25 µg |
| Quantitation Method |
Please see our FAQ |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
DNA from LCL
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Ethnicity
|
GERMAN/POLISH/ENGLISH/CZECH/IRISH/HUNGARIAN
|
|
Country of Origin
|
USA
|
|
Family Member
|
1
|
|
Family History
|
N
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
Dynamin 2 |
| Chromosomal Location |
19p13.2 |
| Allelic Variant 1 |
602378.0007; CENTRONUCLEAR MYOPATHY 1 |
| Identified Mutation |
GLU368LYS; In a French proband with centronuclear myopathy (160150), Bitoun et al. (2005) found an 1102G-to-A transition in exon 8 of the DNM2 gene that resulted in a glu368-to-lys amino acid substitution (E368K). The mutation occurred de novo.
Tosch et al. (2006) reported this mutation in heterozygosity in a 36-year-old woman with centronuclear myopathy who presented with neonatal hypotonia, muscle weakness, and ophthalmoparesis. She also carried a heterozygous missense mutation in the myotubularin-related protein-14 gene (MTMR14; 611089.0002). Both mutations occurred de novo. The report raised the possibility of MTMR14 being a modifier of the phenotype in some cases of centronuclear myopathy. |
| Remarks |
Clinically affected; able to run with both feet leaving the ground; walks without assistance greater than 10 steps; using genomic DNA, PCR was used to amplify exon 8 of the DNM2 gene; bi-directional sequence analysis was performed to evaluate for the mutation in the DNM2 gene; a heterozygous G>A nucleotide change was identified; this missense mutation leads to the replacement of the normal glutamic acid codon (GAG) with a lysine codon (AAG) at position 368 of the resultant protein GLU368LYS (E368K); unaffected father is GM23795(Lymph); unaffected mother is GM23794(Lymph); unaffected brother is GM23793(Lymph). |
|